http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0228108-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f4c2477bdea308bc9dec3feded37457
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-08
filingDate 1989-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee73791781ed87fa9d2ef74121d74854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dd1d22640ccddd1c967a4668accb33b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48d74b3c44e774824d528a50014bd4d0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51ab5b691a918a35bf0984ef63ddadea
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cad1688be4778caa2a09a28f4b6dbe31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e08452fc18115785bbd63a030b76d77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d31d2792590eebb4df3b385d5921b58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccbb1a58925709ebdb88d56961d85a7f
publicationDate 1990-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H0228108-A
titleOfInvention Preventive and treating agent for disease caused by immunological dysfunction
abstract PURPOSE: To obtain the subject preventive and treating agent, containing a specific β,γ-dihydropolyprenyl alcohol derivative and having action of normalizing human and animal immunological function and enhancing infection resistance. n CONSTITUTION: A preventive and treating agent containing a compound expressed by the formula (n is 5-7: R is H, 1-6C alkyl, acetyl or benzoyl), e.g., 3,7,11,15,19,23,27,31-octamethyl-6,10,14,18,22,26,30-dotriacontaheptan-1-ol, as an active ingredient. The above-mentioned composition is effective against rheumarthritis, autoimmune disease, cancer, asthma and various infectious diseases for humans and porcine, bovine diarrhea, porcine, avian, bovine pneumonia, etc., for animals. The dose for humans is within the range of 10-4000mg, preferably 50-500mg per day for an adult. n COPYRIGHT: (C)1990,JPO&Japio
priorityDate 1989-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID240
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID9913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394823

Total number of triples: 33.